{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T21:45:38Z","timestamp":1795211138612,"version":"4.10.3"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01GM127353"],"award-info":[{"award-number":["R01GM127353"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-022-00925-y","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T12:03:10Z","timestamp":1660910590000},"page":"992-1003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries"],"prefix":"10.1038","volume":"6","author":[{"given":"Joel J.","family":"Credle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puwanat","family":"Sangkhapreecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwen Alice","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Ji","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azaan","family":"Wilbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Morgenlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Rastegar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahana","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biju","family":"Parekkadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan N.","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Roederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan M.","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron A. R.","family":"Tobian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Zyskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan I.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi Z.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Mammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7863-196X","authenticated-orcid":false,"given":"H.","family":"Benjamin Larman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"925_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/ana.23840","volume":"73","author":"HB Larman","year":"2013","unstructured":"Larman, H. B. et al. Cytosolic 5\u2032-nucleotidase 1A autoimmunity in sporadic inclusion body myositis. Ann. Neurol. 73, 408\u2013418 (2013).","journal-title":"Ann. Neurol."},{"key":"925_CR2","doi-asserted-by":"publisher","first-page":"aaa0698","DOI":"10.1126\/science.aaa0698","volume":"348","author":"GJ Xu","year":"2015","unstructured":"Xu, G. J. et al. Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome. Science 348, aaa0698 (2015).","journal-title":"Science"},{"key":"925_CR3","doi-asserted-by":"publisher","unstructured":"Shrock, E. et al. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science https:\/\/doi.org\/10.1126\/science.abd4250 (2020).","DOI":"10.1126\/science.abd4250"},{"key":"925_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20622-1","volume":"12","author":"DR Monaco","year":"2021","unstructured":"Monaco, D. R. et al. Profiling serum antibodies with a pan allergen phage library identifies key wheat allergy epitopes. Nat. Commun. 12, 379 (2021).","journal-title":"Nat. Commun."},{"key":"925_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.immuni.2021.12.004","volume":"55","author":"T Venkataraman","year":"2022","unstructured":"Venkataraman, T. et al. Analysis of antibody binding specificities in twin and SNP-genotyped cohorts reveals that antiviral antibody epitope selection is a heritable trait. Immunity 55, 174\u2013184.e5 (2022).","journal-title":"Immunity"},{"key":"925_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nrd2006","volume":"5","author":"SF Kingsmore","year":"2006","unstructured":"Kingsmore, S. F. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat. Rev. Drug Discov. 5, 310\u2013320 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"925_CR7","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S1074-5521(00)90067-X","volume":"8","author":"T Kodadek","year":"2001","unstructured":"Kodadek, T. Protein microarrays: prospects and problems. Chem. Biol. 8, 105\u2013115 (2001).","journal-title":"Chem. Biol."},{"key":"925_CR8","first-page":"1","volume":"328","author":"N Ramachandran","year":"2006","unstructured":"Ramachandran, N., Hainsworth, E., Demirkan, G. & LaBaer, J. On-chip protein synthesis for making microarrays. Methods Mol. Biol. 328, 1\u201314 (2006).","journal-title":"Methods Mol. Biol."},{"key":"925_CR9","first-page":"79","volume":"375","author":"S Rungpragayphan","year":"2007","unstructured":"Rungpragayphan, S., Yamane, T. & Nakano, H. SIMPLEX: single-molecule PCR-linked in vitro expression: a novel method for high-throughput construction and screening of protein libraries. Methods Mol. Biol. 375, 79\u201394 (2007).","journal-title":"Methods Mol. Biol."},{"key":"925_CR10","doi-asserted-by":"crossref","unstructured":"Zhu, J. et al. Protein interaction discovery using parallel analysis of translated ORFs (PLATO). Nat. Biotechnol. 31, 331\u2013334 (2013).","DOI":"10.1038\/nbt.2539"},{"key":"925_CR11","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1002\/anie.201808956","volume":"58","author":"G Liszczak","year":"2019","unstructured":"Liszczak, G. & Muir, T. W. Nucleic acid-barcoding technologies: Converting DNA sequencing into a broad-spectrum molecular counter. Angew. Chem. Int. Ed. Engl. 58, 4144\u20134162 (2019).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"925_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1021\/cb800025k","volume":"3","author":"GV Los","year":"2008","unstructured":"Los, G. V. et al. HaloTag: a novel protein labeling technology for cell imaging and protein analysis. ACS Chem. Biol. 3, 373\u2013382 (2008).","journal-title":"ACS Chem. Biol."},{"key":"925_CR13","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1093\/nar\/gkz1086","volume":"48","author":"J Yazaki","year":"2020","unstructured":"Yazaki, J. et al. HaloTag-based conjugation of proteins to barcoding-oligonucleotides. Nucleic Acids Res. 48, e8 (2020).","journal-title":"Nucleic Acids Res."},{"key":"925_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/BOR.0000000000000776","volume":"33","author":"Y Liu","year":"2021","unstructured":"Liu, Y., Sawalha, A. H. & Lu, Q. COVID-19 and autoimmune diseases. Curr. Opin. Rheumatol. 33, 155\u2013162 (2021).","journal-title":"Curr. Opin. Rheumatol."},{"key":"925_CR15","doi-asserted-by":"publisher","unstructured":"Knight, J. S. et al. The intersection of COVID-19 and autoimmunity. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI154886 (2021).","DOI":"10.1172\/JCI154886"},{"key":"925_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","volume":"595","author":"EY Wang","year":"2021","unstructured":"Wang, E. Y. et al. Diverse functional autoantibodies in patients with COVID-19. Nature 595, 283\u2013288 (2021).","journal-title":"Nature"},{"key":"925_CR17","doi-asserted-by":"publisher","unstructured":"Bastard, P. et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.abl4340 (2021).","DOI":"10.1126\/sciimmunol.abl4340"},{"key":"925_CR18","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/imcb.12495","volume":"99","author":"MS Abers","year":"2021","unstructured":"Abers, M. S. et al. Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19. Immunol. Cell Biol. 99, 917\u2013921 (2021).","journal-title":"Immunol. Cell Biol."},{"key":"925_CR19","doi-asserted-by":"publisher","unstructured":"Mohammad, F., Green, R. & Buskirk, A. R. A systematically-revised ribosome profiling method for bacteria reveals pauses at single-codon resolution. eLife https:\/\/doi.org\/10.7554\/eLife.42591 (2019).","DOI":"10.7554\/eLife.42591"},{"key":"925_CR20","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nature13761","volume":"515","author":"L Gu","year":"2014","unstructured":"Gu, L. et al. Multiplex single-molecule interaction profiling of DNA-barcoded proteins. Nature 515, 554\u2013557 (2014).","journal-title":"Nature"},{"key":"925_CR21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nmeth.1638","volume":"8","author":"X Yang","year":"2011","unstructured":"Yang, X. et al. A public genome-scale lentiviral expression library of human ORFs. Nat. Methods 8, 659\u2013661 (2011).","journal-title":"Nat. Methods"},{"key":"925_CR22","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","volume":"183","author":"CR Consiglio","year":"2020","unstructured":"Consiglio, C. R. et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell 183, 968\u2013981 e967 (2020).","journal-title":"Cell"},{"key":"925_CR23","doi-asserted-by":"publisher","unstructured":"Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science https:\/\/doi.org\/10.1126\/science.abd4585 (2020).","DOI":"10.1126\/science.abd4585"},{"key":"925_CR24","doi-asserted-by":"publisher","unstructured":"Zuo, Y. et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.abd3876 (2020).","DOI":"10.1126\/scitranslmed.abd3876"},{"key":"925_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.158362","volume":"7","author":"L Casciola-Rosen","year":"2022","unstructured":"Casciola-Rosen, L. et al. IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function. JCI Insight. 7, 1\u201318 (2022).","journal-title":"JCI Insight."},{"key":"925_CR26","doi-asserted-by":"publisher","unstructured":"Woodruff, M. C., Ramonell, R. P., Lee, F. E. & Sanz, I. Relaxed peripheral tolerance drives de novo autoreactivity in severe COVID-19. medRxiv https:\/\/doi.org\/10.1101\/2020.10.21.20216192 (2021).","DOI":"10.1101\/2020.10.21.20216192"},{"key":"925_CR27","doi-asserted-by":"publisher","first-page":"D769","DOI":"10.1093\/nar\/gkw946","volume":"45","author":"D Wang","year":"2017","unstructured":"Wang, D. et al. AAgAtlas 1.0: a human autoantigen database. Nucleic Acids Res. 45, D769\u2013D776 (2017).","journal-title":"Nucleic Acids Res."},{"key":"925_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/acr.22600","volume":"68","author":"TE Lloyd","year":"2016","unstructured":"Lloyd, T. E. et al. Cytosolic 5\u2032-nucleotidase 1A as a target of circulating autoantibodies in autoimmune diseases. Arthritis Care Res. 68, 66\u201371 (2016).","journal-title":"Arthritis Care Res."},{"key":"925_CR29","doi-asserted-by":"publisher","unstructured":"Gupta, S., Nakabo, S., Chu, J., Hasni, S. & Kaplan, M. J. Association between anti-interferon-alpha autoantibodies and COVID-19 in systemic lupus erythematosus. medRxiv https:\/\/doi.org\/10.1101\/2020.10.29.20222000 (2020).","DOI":"10.1101\/2020.10.29.20222000"},{"key":"925_CR30","doi-asserted-by":"publisher","unstructured":"Xu, G. J. et al. Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer. Proc. Natl Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.1615990113 (2016).","DOI":"10.1073\/pnas.1615990113"},{"key":"925_CR31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.immuni.2021.12.004","volume":"55","author":"T Venkataraman","year":"2022","unstructured":"Venkataraman, T. et al. Analysis of antibody binding specificities in twin and SNP-genotyped cohorts reveals that antiviral antibody epitope selection is a heritable trait. Immunity 55, 174\u2013184 e175 (2022).","journal-title":"Immunity"},{"key":"925_CR32","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius, M. et al. Simultaneous epitope and transcriptome measurement in single cells. Nat. Methods 14, 865\u2013868 (2017).","journal-title":"Nat. Methods"},{"key":"925_CR33","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.cell.2019.11.003","volume":"179","author":"I Setliff","year":"2019","unstructured":"Setliff, I. et al. High-throughput mapping of B cell receptor sequences to antigen specificity. Cell 179, 1636\u20131646 e1615 (2019).","journal-title":"Cell"},{"key":"925_CR34","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41587-019-0207-y","volume":"37","author":"SK Saka","year":"2019","unstructured":"Saka, S. K. et al. Immuno-SABER enables highly multiplexed and amplified protein imaging in tissues. Nat. Biotechnol. 37, 1080\u20131090 (2019).","journal-title":"Nat. Biotechnol."},{"key":"925_CR35","doi-asserted-by":"publisher","first-page":"103506","DOI":"10.1016\/j.ebiom.2021.103506","volume":"71","author":"GD Roman-Melendez","year":"2021","unstructured":"Roman-Melendez, G. D. et al. Citrullination of a phage-displayed human peptidome library reveals the fine specificities of rheumatoid arthritis-associated autoantibodies. EBioMedicine 71, 103506 (2021).","journal-title":"EBioMedicine"},{"key":"925_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cels.2020.08.013","volume":"11","author":"GD Roman-Melendez","year":"2020","unstructured":"Roman-Melendez, G. D., Venkataraman, T., Monaco, D. R. & Larman, H. B. Protease activity profiling via programmable phage display of comprehensive proteome-scale peptide libraries. Cell Syst. 11, 375\u2013381 e374 (2020).","journal-title":"Cell Syst."},{"key":"925_CR37","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1128\/JVI.00272-10","volume":"84","author":"M Mordstein","year":"2010","unstructured":"Mordstein, M. et al. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J. Virol. 84, 5670\u20135677 (2010).","journal-title":"J. Virol."},{"key":"925_CR38","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1128\/JVI.80.9.4501-4509.2006","volume":"80","author":"N Ank","year":"2006","unstructured":"Ank, N. et al. Lambda interferon (IFN-\u03bb), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J. Virol. 80, 4501\u20134509 (2006).","journal-title":"J. Virol."},{"key":"925_CR39","doi-asserted-by":"publisher","unstructured":"Busnadiego, I. et al. Antiviral activity of type I, II, and III interferons counterbalances ACE2 inducibility and restricts SARS-CoV-2. mBio https:\/\/doi.org\/10.1128\/mBio.01928-20 (2020).","DOI":"10.1128\/mBio.01928-20"},{"key":"925_CR40","doi-asserted-by":"publisher","unstructured":"Vanderheiden, A. et al. Type I and type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures. J. Virol. https:\/\/doi.org\/10.1128\/JVI.00985-20 (2020).","DOI":"10.1128\/JVI.00985-20"},{"key":"925_CR41","doi-asserted-by":"publisher","first-page":"107863","DOI":"10.1016\/j.celrep.2020.107863","volume":"32","author":"ML Stanifer","year":"2020","unstructured":"Stanifer, M. L. et al. Critical role of type III interferon in controlling SARS-CoV-2 infection in human intestinal epithelial cells. Cell Rep. 32, 107863 (2020).","journal-title":"Cell Rep."},{"key":"925_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","volume":"22","author":"IE Galani","year":"2021","unstructured":"Galani, I. E. et al. Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison. Nat. Immunol. 22, 32\u201340 (2021).","journal-title":"Nat. Immunol."},{"key":"925_CR43","doi-asserted-by":"publisher","first-page":"13958","DOI":"10.1074\/jbc.AC120.013788","volume":"295","author":"U Felgenhauer","year":"2020","unstructured":"Felgenhauer, U. et al. Inhibition of SARS-CoV-2 by type I and type III interferons. J. Biol. Chem. 295, 13958\u201313964 (2020).","journal-title":"J. Biol. Chem."},{"key":"925_CR44","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1093\/cid\/ciaa453","volume":"71","author":"TR O\u2019Brien","year":"2020","unstructured":"O\u2019Brien, T. R. et al. Weak induction of interferon expression by severe acute respiratory syndrome coronavirus 2 supports clinical trials of interferon-\u03bb to treat early coronavirus disease 2019. Clin. Infect. Dis. 71, 1410\u20131412 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"925_CR45","doi-asserted-by":"publisher","first-page":"e12465","DOI":"10.15252\/emmm.202012465","volume":"12","author":"E Andreakos","year":"2020","unstructured":"Andreakos, E. & Tsiodras, S. COVID-19: lambda interferon against viral load and hyperinflammation. EMBO Mol. Med. 12, e12465 (2020).","journal-title":"EMBO Mol. Med."},{"key":"925_CR46","doi-asserted-by":"publisher","unstructured":"Prokunina-Olsson, L. et al. COVID-19 and emerging viral infections: The case for interferon lambda. J. Exp. Med. https:\/\/doi.org\/10.1084\/jem.20200653 (2020).","DOI":"10.1084\/jem.20200653"},{"key":"925_CR47","doi-asserted-by":"publisher","unstructured":"Feld, J. J. et al. Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial. Lancet Respir. Med. https:\/\/doi.org\/10.1016\/S2213-2600(20)30566-X (2021).","DOI":"10.1016\/S2213-2600(20)30566-X"},{"key":"925_CR48","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1002\/pmic.200500654","volume":"6","author":"MA Jongsma","year":"2006","unstructured":"Jongsma, M. A. & Litjens, R. H. Self-assembling protein arrays on DNA chips by auto-labeling fusion proteins with a single DNA address. Proteomics 6, 2650\u20132655 (2006).","journal-title":"Proteomics"},{"key":"925_CR49","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.chembiol.2008.01.007","volume":"15","author":"A Gautier","year":"2008","unstructured":"Gautier, A. et al. An engineered protein tag for multiprotein labeling in living cells. Chem. Biol. 15, 128\u2013136 (2008).","journal-title":"Chem. Biol."},{"key":"925_CR50","doi-asserted-by":"publisher","first-page":"eaas9098","DOI":"10.1126\/sciadv.aas9098","volume":"4","author":"AJ Samelson","year":"2018","unstructured":"Samelson, A. J. et al. Kinetic and structural comparison of a protein\u2019s cotranslational folding and refolding pathways. Sci. Adv. 4, eaas9098 (2018).","journal-title":"Sci. Adv."},{"key":"925_CR51","doi-asserted-by":"publisher","unstructured":"Tosi, L. et al. Long-adapter single-strand oligonucleotide probes for the massively multiplexed cloning of kilobase genome regions. Nat. Biomed. Eng. https:\/\/doi.org\/10.1038\/s41551-017-0092 (2017).","DOI":"10.1038\/s41551-017-0092"},{"key":"925_CR52","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1038\/s41596-018-0088-4","volume":"14","author":"D Mohan","year":"2019","unstructured":"Mohan, D. et al. Publisher correction: PhIP-seq characterization of serum antibodies using oligonucleotide-encoded peptidomes. Nat. Protoc. 14, 2596 (2019).","journal-title":"Nat. Protoc."},{"key":"925_CR53","doi-asserted-by":"publisher","first-page":"16 31 11","DOI":"10.1002\/0471142727.mb1631s108","volume":"108","author":"C Tuckey","year":"2014","unstructured":"Tuckey, C., Asahara, H., Zhou, Y. & Chong, S. Protein synthesis using a reconstituted cell-free system. Curr. Protoc. Mol. Biol. 108, 16 31 11\u201316 31 22 (2014).","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"925_CR54","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.1172\/JCI142004","volume":"130","author":"SL Klein","year":"2020","unstructured":"Klein, S. L. et al. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. J. Clin. Invest. 130, 6141\u20136150 (2020).","journal-title":"J. Clin. Invest."},{"key":"925_CR55","doi-asserted-by":"publisher","first-page":"144","DOI":"10.7326\/M20-3905","volume":"174","author":"BT Garibaldi","year":"2021","unstructured":"Garibaldi, B. T. et al. Patient trajectories among persons hospitalized for COVID-19. Ann. Intern. Med. 174, 144 (2021).","journal-title":"Ann. Intern. Med."},{"key":"925_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2021.2816","volume":"4","author":"I Zyskind","year":"2021","unstructured":"Zyskind, I. et al. SARS-CoV-2 seroprevalence and symptom onset in culturally-linked Orthodox Jewish communities across multiple regions in the United States. JAMA Open Netw. 4, 1\u20139 (2021).","journal-title":"JAMA Open Netw."},{"key":"925_CR57","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","volume":"23","author":"MR Rose","year":"2013","unstructured":"Rose, M. R. & Group, E. I. W. 188th ENMC International Workshop: inclusion body myositis, 2\u20134 December 2011, Naarden, The Netherlands. Neuromuscul. Disord. 23, 1044\u20131055 (2013).","journal-title":"Neuromuscul. Disord."},{"key":"925_CR58","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1093\/bioinformatics\/bty141","volume":"34","author":"Z Wei","year":"2018","unstructured":"Wei, Z., Zhang, W., Fang, H., Li, Y. & Wang, X. esATAC: an easy-to-use systematic pipeline for ATAC-seq data analysis. Bioinformatics 34, 2664\u20132665 (2018).","journal-title":"Bioinformatics"},{"key":"925_CR59","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-022-00925-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-022-00925-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-022-00925-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T09:27:22Z","timestamp":1669282042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-022-00925-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":59,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["925"],"URL":"https:\/\/doi.org\/10.1038\/s41551-022-00925-y","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"assertion":[{"value":"7 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.B.L., J.J.C., J.G. and P.S. are listed as inventors on a patent application filed by Johns Hopkins University that covers the MIPSA technology. H.B.L. is a founder of Portal Bioscience, Alchemab and ImmuneID, and an advisor to TScan Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}